Literature DB >> 8591574

Do physicians estimate reliably the cardiovascular risk of hypertensive patients?.

G Chatellier1, A Blinowska, J Menard, P Degoulet.   

Abstract

For hypertension management, it is increasingly recommended to individualize treatment according to the individual patient's characteristics. However, the ability of physicians to predict the patient's risk in the absence of a computer aid is unknown. Our aim was to determine if senior hypertension specialists were able to assess reproducibly cardiovascular disease (cvd) risk in hypertensive patients. The records of 100 patients were selected at random from the ARTEMIS database. The group comprised 53% of males, mean age was 43.7 (15), blood pressure 160 (25) / 99 (12) mmhg and serum cholesterol 5.6 (1.1) mmol/l. The records were summarized on a standardized form. Nineteen items were devoted to general characteristics and medical history of patients, 15 to clinical examination and 7 to biological tests. These items have been chosen because they were used in the framingham cvd risk prediction equation and/or had decisional value in a bayesian program designed for secondary hypertension diagnosis. Six physicians, twice at one month intervals, assigned each patient to one of the three categories of risk (low, moderate, high). The order of cases was randomized. Chance corrected agreement (intra-physician agreement) between the two estimations was only moderate except for one expert (kappa values: 0.658, 0,543, 0.439, 0.363, 0.328 and 0.207 for each expert, respectively). The proportion of patients assigned by each physician to each category ranged from 22.7% to 77.3% for the low risk, and from 4.5% to 43.9% for the high risk category. One physician overestimated risk, one underestimated it and the three others were in keeping with framingham predictions. Bias and lack of reproducibility influence physician judgment in assessing cvd risk of hypertensive patients. Application of computer aids could result in more rational assessments and better decision making.

Entities:  

Mesh:

Year:  1995        PMID: 8591574

Source DB:  PubMed          Journal:  Medinfo        ISSN: 1569-6332


  10 in total

1.  The number needed to treat: a clinically useful nomogram in its proper context.

Authors:  G Chatellier; E Zapletal; D Lemaitre; J Menard; P Degoulet
Journal:  BMJ       Date:  1996-02-17

2.  Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial.

Authors:  A A Montgomery; T Fahey; T J Peters; C MacIntosh; D J Sharp
Journal:  BMJ       Date:  2000-03-11

3.  Estimation of cardiovascular risk in hypertensive patients in primary care.

Authors:  A A Montgomery; T Fahey; C MacKintosh; D J Sharp; T J Peters
Journal:  Br J Gen Pract       Date:  2000-02       Impact factor: 5.386

Review 4.  Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.

Authors:  Stacey Sheridan; Michael Pignone; Cynthia Mulrow
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

5.  A new method for determining physician decision thresholds using empiric, uncertain recommendations.

Authors:  Michael V Boland; Harold P Lehmann
Journal:  BMC Med Inform Decis Mak       Date:  2010-04-08       Impact factor: 2.796

6.  Comparison of models for predicting outcomes in patients with coronary artery disease focusing on microsimulation.

Authors:  Masoud Amiri; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2012-08

Review 7.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.

Authors:  Stacey L Sheridan; Eric Crespo
Journal:  BMC Health Serv Res       Date:  2008-03-20       Impact factor: 2.655

8.  Physicians' ability to predict the risk of coronary heart disease.

Authors:  Michael Pignone; Christopher J Phillips; Tom A Elasy; Alicia Fernandez
Journal:  BMC Health Serv Res       Date:  2003-07-11       Impact factor: 2.655

9.  Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty.

Authors:  Salima Juma; Benjamin K A Thomson; Charmaine E Lok; Catherine M Clase; Peter G Blake; Louise Moist
Journal:  BMC Nephrol       Date:  2013-08-13       Impact factor: 2.388

10.  Providing clinicians with a patient's 10-year cardiovascular risk improves their statin prescribing: a true experiment using clinical vignettes.

Authors:  Nishant K Sekaran; Jeremy B Sussman; Anna Xu; Rodney A Hayward
Journal:  BMC Cardiovasc Disord       Date:  2013-10-22       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.